Maryland Cannabis News

Maryland's proposed cannabis regulations include extending conditional license deadlines from 18 to 24 months, strengthening contamination controls, reducing fees, and increasing operational flexibility for dispensaries and micro-licensees.

The summary covers several cannabis and psychedelics policy updates, including conflicting industry stances on intoxicating hemp products (one group urging recriminalization, another urging regulation like alcohol), Nebraska AG's warning against buying marijuana, the Maryland task force's recommendation for phased psychedelics legalization starting with psilocybin, and FBI data showing marijuana arrests as a primary driver of drug war enforcement. Other updates include South Dakota's recommendation for tighter medical cannabis and hemp regulations, various state-level regulatory actions and new laws, and financial reports from several cannabis businesses.

Over 50 alcohol distributors are opposing efforts in Congress to ban intoxicating hemp products, arguing that the cannabis market helps sustain their industry as alcohol demand shifts downward. They urge lawmakers to regulate and tax these products like alcohol, drawing parallels to the failure of alcohol prohibition. The article notes division among alcohol stakeholders, with some major industry associations and consumer trade groups actually supporting a ban, at least temporarily. Additionally, 39 state and territory attorneys general are calling for clearer federal definitions and regulations for cannabinoid products. The issue remains contested in Congress, with lawmakers like Sen. Mitch McConnell pushing for a ban while Sen. Rand Paul opposes it and advocates for more lenient regulations.

The Maryland Task Force on Responsible Use of Natural Psychedelic Substances released a final report recommending a multi-phase framework for legal, therapeutic access to natural psychedelics, starting with psilocybin. The plan involves phased implementation of medical/therapeutic use, supervised adult use, deprioritization measures, and eventually commercial sales, with the goal of ensuring safe, broad, and equitable access. The task force does not support delaying state action pending future FDA approval and emphasizes an "ensemble model" approach that balances public health, patient safety, equity, and scientific integrity, positioning Maryland as a potential national leader in psychedelic policy reform. The report also estimates potential client numbers and consumer spending if psilocybin is legalized.

Steve Bevan, a key figure in drafting the hemp language in the 2018 Farm Bill, argues that the emergence of intoxicating cannabinoid products is not due to a "loophole" but rather the intentional language added to the law and subsequent inaction by lawmakers and regulators like the FDA. Bevan's letter to GOP leaders opposes a proposed ban, suggesting that simple age restrictions and regulation are the solution, not prohibition, which he claims would only boost the illicit market. He suggests that state attorneys general advocating for a ban are likely motivated by competition with the cannabis businesses in their states. The article also notes that major alcohol industry associations support a ban and highlights the disagreement among GOP lawmakers, with Senator Rand Paul opposing the ban aggressively, while Senator Mitch McConnell pushes for it. Congress has two options: prohibit the products or create a regulatory framework with quality standards and age requirements.

D.C.'s medical cannabis sales were $7.8 million in September, down 5% from August, but manufacturing, concentrate, and infused product sales showed strong growth, with out-of-District patients from Maryland, Virginia, and Florida as key buyers. Maryland provided a $217,000 grant for cannabis workforce training, police paused the "Green Lab" study due to high volunteer interest, and Virginia's unestablished retail cannabis market is becoming a focus ahead of the gubernatorial race, coinciding with a new online training program for healthcare professionals.

Major alcohol industry associations are urging Congress to temporarily ban intoxicating hemp products until a federal regulatory framework is established. They argue that the ambiguous language in the 2018 Farm Bill has led to an unregulated market for intoxicating cannabinoids like delta-8 and delta-9 THC. This push aligns with some lawmakers, like Sen. Mitch McConnell and Rep. Andy Harris, who support a ban, and 39 state attorneys general. However, other alcohol interests, such as Wine & Spirits Wholesalers of America (WSWA), oppose a full prohibition, and Sen. Rand Paul is strongly against a ban, arguing it would devastate the hemp industry and preferring regulatory reform, such as his proposed HEMP Act to triple the legal THC concentration.

The summary covers several cannabis-related developments: a lawyer is "hopeful" yet "nervous" about the Supreme Court taking up a federal prohibition lawsuit; the Minnesota AG defended signing a letter to recriminalize hemp THC products while seeking state carve-outs; Massachusetts is considering employment protections for marijuana users; Seth Rogen commented on the push to ban THC drinks; a Nebraska tribe claims punishment for its legalization plan; Sen. Mitch McConnell's office disputed claims he's ending his push for a hemp THC ban; Colorado's governor proposed transferring excess marijuana revenue to education; and Planet 13 Holdings is divesting a California retail store and closing a cultivation facility.

Employees at Nature's Care and Wellness, a medical cannabis dispensary in Cecil County, are accusing management of retaliation and intimidation after they started efforts to unionize with UFCW Local 27.

Minnesota Attorney General Keith Ellison is defending his decision to sign a bipartisan letter urging Congress to federally ban the sale of intoxicating hemp products, despite supporting Minnesota's regulated THC edible industry. Ellison argues the federal 2018 Farm Bill created an unintended "loophole" leading to unregulated, highly potent THC products entering the state and being marketed to children. His intent is to close this loophole and protect Minnesota's regulations. The AG's office clarified they support a federal "carve-out" for states with adequate regulatory schemes or an enforcement discretion memo. Industry stakeholders and some lawmakers, like Sen. Rand Paul (R-KY), oppose a total ban, arguing it would devastate the market. Other lawmakers, like Sen. Mitch McConnell (R-KY), are pushing for an outright ban.

The summary covers several cannabis and psychedelics policy updates, including Sen. Rand Paul's threat to block a government shutdown bill over a provision that would recriminalize hemp products with THC, Idaho activists launching a medical cannabis legalization initiative for 2026, a poll showing Canadians believe the cannabis industry is an important economic contributor, and Arizona approving a clinical trial for whole mushroom psilocybin to treat PTSD in veterans and first responders. It also mentions a study on marijuana aroma and terpenes, state-level policy news, international developments like Lebanon legalizing medical cannabis cultivation, and business/culture news.

In September, D.C.'s medical cannabis sales totaled $7.8 million, a 5% drop from August due to a seasonal slowdown, although manufacturing, concentrate, and infused product sales showed strong growth, with Maryland, Virginia, and Florida patients being top buyers. Regional developments included a $217,000 Maryland grant for cannabis workforce training, a temporary pause in a police-run cannabis impairment study due to high volunteer response, renewed focus on Virginia's unestablished retail market ahead of the gubernatorial race, and the launch of a new online training program for healthcare practitioners.

Multistate operator MariMed Inc. is exiting the Missouri market immediately following a strategic review of its business operations there. The company had been managing the Missouri operations of another licensed cannabis operator since 2024 under an agreement while awaiting license transfer approval, but will no longer manage the facility or seek the transfer. MariMed expects this exit to improve its financial performance and allow management to focus resources on higher-return opportunities, as it continues to own or manage 13 dispensaries and six cultivation and processing facilities across Delaware, Illinois, Maryland, Massachusetts, Ohio, and Pennsylvania.

A bipartisan coalition of 39 state and territory attorneys general is urging Congress to clarify the federal definition of hemp in the 2018 Farm Bill and impose regulations to prevent the sale of intoxicating cannabinoid products, arguing that the current interpretation has been exploited to sell synthetic THC products, often marketed to minors. They are asking for legislative changes to make these products illegal. Industry stakeholders, however, express concern that a ban could jeopardize the entire hemp market and suggest a middle-ground approach with age-gating and safety standards. Separately, Senator Rand Paul (R-KY) is advocating for a study into state regulatory models and has proposed legislation to triple the legal THC concentration for hemp, opposing efforts by Senator Mitch McConnell (R-KY) to champion criminalization language.

CULTA appointed Joseph Andreae as CEO. He brings experience from other cannabis programs and will focus on building an experienced leadership team, leveraging infrastructure for product quality, maintaining company culture, and differentiating the company through new values prioritizing staff and customers, cultivation integrity, and elevating the perception of cannabis.

A seasoned cannabis executive will help a Maryland company advance its commitment to craft, quality, and community.

The newsletter covers several cannabis and drug policy updates, including marijuana companies petitioning the U.S. Supreme Court to challenge federal prohibition, a hemp dispute in Congress, and state updates from Kentucky (15,000 registered medical cannabis patients) and Texas (expanding medical marijuana access). A new study indicates more Americans now use marijuana than smoke cigarettes. Other topics include state-level regulatory updates, a Texas DA lawsuit over refusing to enforce drug laws, a rejection of New York regulators' request on licensing residency privileges, and international news on German cannabis imports. The science section notes that cannabinoids offer modest, condition-specific pain relief and a study on psilocybin-assisted therapy for depression. Lastly, Canadian retailers sold C$498.7 million worth of legal marijuana products in August.

Maryland awarded a $217K EARN grant to CannaWorkforce to expand cannabis workforce training in 2026, which includes new laboratory technician programs and supports job placement for unemployed and underemployed Maryland residents.

The National Association of Attorneys General (NAAG), representing 39 state and territory attorneys general, sent a letter to Congress seeking clarification on the federal definition of hemp in the 2018 Farm Bill. The letter argues that the growing market for hemp-derived THC products is based on a misinterpretation of the law and asks Congress to clarify the definition of hemp to ensure these "harmful products are illegal."

West Virginia's medical cannabis program has collected approximately $34 million in taxes and fees since 2021, which state law requires be used for a medical cannabis research program, substance use disorder resources, and law enforcement training. However, the money remains unspent because cannabis is illegal at the federal level, and traditional banks refused to hold the funds. The money is currently held by a credit union, and the treasurer's office states it will remain unallocated until federal law changes. Other states with legal cannabis markets are spending their tax revenue. Lawmakers who drafted the original legislation expressed surprise that the funds are stockpiling. If the money were distributed today, it would be allocated to public health, substance abuse programs, and law enforcement training.

A Maryland cannabis company signed an agreement to expand its presence nationally.

D.C. dispensaries face oversupply, reducing sales. A court ruling set a precedent against nuisance marijuana smoking. Illegal operations like Tobacco King & Vape and Mother Earth Mushroom Church were shut down. Maryland police started the "Cannabis Green Lab" for impairment research. Virginia license applicants face tough competition and regulations.

The cannabis market in D.C. is growing rapidly, potentially too fast. With a high number of dispensaries compared to Maryland and Pennsylvania, sales per store are decreasing and prices remain elevated, indicating that more shops do not necessarily lead to a stronger market.

The newsletter provides updates on cannabis-related legislation and political developments across the US, including contrasting views from NJ governor candidates, advancing cannabis and hemp bills in OH and PA, and the approval of a timeline for dispensary licenses in RI. It also covers federal lobbying efforts by alcohol and other companies around hemp drinks, a pause in a judicial nomination amid a marijuana legalization campaign investigation, and research into CBD-like compounds developed from caraway seeds. International, scientific, business, and cultural cannabis news are also included.

The summary covers various cannabis-related developments, including: US senators discussing if rescheduling cannabis would aid banking legislation; a scheduled Pennsylvania Senate vote on a cannabis control board bill; a Massachusetts official expressing concern over proposed recriminalization initiatives impacting tax revenue; NYC mayoral candidates discussing cannabis use; an overwhelming volunteer turnout for a Maryland police DUI recognition training event involving smoking marijuana; a study suggesting legalization is associated with reduced opioid use among cancer patients; hearings on bills to reduce regulatory burden in Michigan and criticism of restrictive rules in Nebraska; federal updates on a Navy Admiral's retirement and a request to ban mention of legalization during a cultivation trial; state-level actions in New Mexico, New York, California, Delaware, Connecticut, U.S. Virgin Islands, Oklahoma, Massachusetts, and Nevada; a local fine reduction in La Crosse County, Wisconsin; science and health studies on pain reduction and post-legalization use prevalence; and business news including an acquisition and Colorado's July sales.

A summary of the Marijuana Moment newsletter includes new FBI data on marijuana arrests, a VA official's comments on psychedelics for veterans, Oklahoma's marijuana legalization initiative deadline, and the Marijuana Policy Project's call for industry and advocacy collaboration. Other topics include studies on cannabis as an opioid alternative, legal challenges to hemp product bans in Ohio, proposed cannabis rules in Missouri, and various state and international cannabis policy updates.

Nearly 188,000 people were arrested for marijuana possession and another 16,000 for selling or growing cannabis in the U.S. last year, according to the FBI's latest annual crime report. While these figures are likely understated due to data inconsistencies, cannabis-related offenses saw a slight decrease from 2023. Despite the reduction, marijuana remains the most common illegal substance for which Americans are arrested. The FBI's data has faced criticism for inconsistencies and incomplete reporting from state and local police, making it challenging to draw accurate policy conclusions. The Drug Enforcement Administration (DEA) also noted that the marijuana rescheduling process remains stalled.

In D.C., Chocolate City Wellness was suspended for 30 days due to illegal cannabis sales. In Maryland, three social equity licensees (Koan Cannabis, Elevated Dispo, and Elevated Releaf) received operational licenses. In Virginia, small cannabis businesses voiced concerns about regulatory fairness.

The latest quarterly tracking poll conducted by Marijuana Moment and NuggMD
shows that cannabis consumers are largely unimpressed with President Donald
Trump’s actions on the issue so far—and that most believe the CBD video the
president posted “does not mean anything” for the prospects of federal
rescheduling.

The D.C. Council extended conditional medical cannabis licenses by 12 months for new operators. Other news includes highlights from the Oct. 8 ABC Board meeting, four unlicensed retailer closures, Maryland’s social equity vendor fair and incubator launch, and Virginia’s 2026 retail cannabis roadmap discussions.

A leading hemp industry organization has sent a letter to President Donald
Trump, applauding him for his role in legalizing the crop during his first
term and imploring him to prevent Congress from “reversing” the reform by
banning hemp products containing any amount of THC.

A Florida appeals court ruled that police cannot search a vehicle based solely on the smell of marijuana, due to the legalization of hemp and medical marijuana in the state. This overturns the "plain smell doctrine" and aligns cannabis searches with other suspected contraband, requiring the odor to be considered as one factor among others. Other states, including Maryland, Minnesota, and Illinois, have also addressed or are addressing similar policies regarding cannabis odor and police searches.

MariMed’s InHouse brand launched its second-annual Help on the Homefront campaign, offering qualifying veterans the chance to win $5,000 to help with housing costs or home improvements. The campaign runs from October 1 to November 30, 2025, with one winner chosen from each of MariMed's four retail markets: Maryland, Massachusetts, Delaware, and Illinois. Veterans aged 21 and over can apply in-store or online, and no purchase is necessary.

D.C. regulators ordered the Temple of Golden Teacher to close due to psilocybin sales, while DC Smoke's license was upheld. ABCA issued fines and made arrests related to unlicensed dispensaries. In Maryland, THC regulation enforcement was restored, and Virginia is launching a safe driving campaign.

The Maryland Cannabis Administration has recalled cannabis products that failed safety compliance testing due to bacterial contamination. Patients and caregivers should check product labels for METRC and production batch numbers.

The provided text summarizes a "Marijuana Moment" newsletter from September 30, 2025. Key points include: the DOJ delaying a marijuana rescheduling challenge, a US citizen freed from Russia over cannabis speaking at a conference, and Ohio marijuana rules changes. It also covers federal, state, local, international, science & health, advocacy, and business news related to cannabis.

*MN’s 1st marijuana event license; KY hemp farmer letter to McConnell;
Study: Anti-rescheduling poll; Snapchat AI blocks cannabis info but OKs
alcohol *

Kentucky hemp farmers are urging Senator Mitch McConnell to abandon his efforts to recriminalize some hemp products, warning of "catastrophic consequences" for their farms and livelihoods. McConnell, who championed the 2018 Farm Bill legalizing hemp, now seeks to ban hemp derivatives with "quantifiable" THC, claiming he never intended to allow intoxicating cannabis products. Farmers argue this would destroy their market and empower the illicit market, advocating instead for responsible regulation like age restrictions and uniform testing. Senator Rand Paul (R-KY) has worked to remove the ban from legislation and is pushing for a bill to triple the legal THC concentration in hemp. The U.S. Hemp Roundtable and an alcohol industry association also oppose the ban, while some GOP lawmakers and a beer industry group express concerns about unregulated hemp products.

D.C. is considering extending conditional licenses to four years due to ABCA crackdowns. Maryland is recalling bacteria-contaminated edibles. Virginia's medical cannabis sales are surging despite patient concerns.

A Republican congressman, James Comer, supports overturning some criminal justice reform policies in Washington D.C., but acknowledges "a trace of racism" in marijuana enforcement. However, he believes advocates have gone too far in expanding these reforms to issues like cashless bail. His committee recently approved a bill to repeal a D.C. law expanding marijuana expungements. Despite his willingness to revisit a rider preventing D.C. from using its own funds for recreational marijuana sales, the House Appropriations Committee has kept the rider intact. Democratic Congresswoman Eleanor Holmes Norton has criticized these actions, arguing they restrict D.C.'s autonomy.

Virginia's new seed-to-sale medical cannabis tracking system, operated by the Virginia Cannabis Control Authority (CCA) and Metrc, has been online for two months, providing real-time data on plants, products, and sales. This system helps the CCA track popular products, plant growth, and sales trends, aiming to protect patients and prevent illegal products. Early data shows nearly half of sales were flower, with concentrates, edibles, and shake trim making up the rest. The CCA plans to create a public dashboard for data transparency. Patients continue to express concerns about high prices and limited access, with some traveling to neighboring states for cheaper products. The system's unveiling coincides with a debate in the General Assembly about legalizing recreational cannabis sales, which lawmakers are considering for as early as 2026. The CCA's current focus remains on refining the medical program and ensuring public safety, with the tracking system allowing regulators to trace products and reduce risks.

The Trump administration is asking a federal court to dismiss a lawsuit
from a Washington, D.C. hemp business challenging the federal government
over a congressional budget restriction that prevents local officials from
establishing and regulating a retail marijuana market.

A Democratic congresswoman is accusing a Republican lawmaker, Rep. Byron Donalds, of hypocrisy for sponsoring legislation to restrict Washington D.C.'s sentencing reform law, despite his own past marijuana and robbery charges being dismissed or expunged. She argues that Donalds was afforded opportunities he is now denying to D.C. youth. The article also details Donalds's mixed record on cannabis policy, including votes against certain marijuana reform efforts despite his personal history, and mentions ongoing congressional interference with D.C.'s cannabis laws, such as the annual appropriations rider preventing recreational marijuana sales.

The Maryland Cannabis Administration has recalled Hi Color Max Chocolate Milk products due to bacterial contamination. This recall of medical cannabis products in Maryland was reported by MJBizDaily.

Senator Rand Paul is concerned about potential legislation that could decimate the hemp industry within the next two weeks, arguing that the cannabis policy movement has become too prohibitionist. He advocates for regulating consumable cannabis products rather than the plant itself, which would ease the burden on farmers and allow for public health precautions without an outright ban. Paul believes that a total ban would create an illegal market and harm livelihoods. He has been working to compromise with other lawmakers and introduced the HEMP Act to increase the legal THC concentration in hemp.

Edible Brands, known for Edible Arrangements, is expanding its cannabis product delivery service, Edibles.com, to 30 states across the U.S., with same-day delivery in several major cities. The company initially tested the service in Texas and has since partnered with cannabis businesses like Wana, Wyld, and Kiva Confections. This expansion comes as states and Congress debate hemp policy, with some proposals aiming to ban hemp products with any amount of THC.

*GOP senator: Congress must “step up” on marijuana; Dem lawmaker talks
Trump & cannabis; OH’s $3B in sales; Study: cannabis as tobacco substitute*

A group of Democratic U.S. Senators are urging congressional leaders to protect hemp legalization in the government spending bill, opposing any language that would harm the American agricultural hemp industry and endanger states' ability to prevent unsafe hemp-derived cannabinoid products from reaching children. They suggest alternatives to a ban, such as restricting sales to adults over 21, standardizing packaging, prohibiting synthetic products, and requiring third-party lab tests. The letter highlights the hemp industry's economic contributions, including 320,000 jobs, $28.4 billion in regulated market activity, and $1.5 billion in state tax revenues.

Maryland's high court has ruled that hemp-derived psychoactive products have always been illegal in the state.

Minnesota dispensaries are now open for adult-use cannabis, with Legacy Cannabis in Duluth being the first state-licensed recreational dispensary. Vireo Growth Inc. is also making its products available, emphasizing community building and responsible access. Previously, adult-use purchases were limited to Native American reservations, but new compacts with tribes are accelerating the market launch.

Sens. Ron Wyden (D-OR) and Jeff Merkley (D-OR) led six other senators on a
letter asking leadership to oppose any move to recriminalize hemp products
with a quantifiable amount of THC, saying it “would deal a fatal blow to
the American farmers who are the foundation of the regulated hemp industry.”

Democratic senators are urging their colleagues to reject a proposed ban on hemp products containing THC, arguing it would destroy the industry. They suggest a regulatory framework instead, including age restrictions, labeling requirements, and testing. This comes after efforts by Sen. Mitch McConnell to recriminalize hemp with quantifiable THC were stripped from a Senate agriculture spending bill. The hemp industry, legalized under the 2018 Farm Bill, supports 320,000 jobs and generates billions in revenue and state tax. Senators Ron Wyden and Jeff Merkley led a letter opposing the ban, while Senator Rand Paul also opposes it and has filed a bill to increase the legal THC concentration in hemp. Concerns have also been raised by the alcohol industry and the U.S. Hemp Roundtable about the lack of clear federal regulations.

Chocolate City Wellness in D.C. has shut down. Maryland reported $18.4M in Q2 cannabis taxes, and delta-8 and delta-10 THC have been ruled illegal in Maryland.

Michigan Senate Democrats are considering a 32 percent wholesale excise tax on marijuana, in addition to the existing 16 percent retail tax, as proposed by Gov. Gretchen Whitmer. This measure aims to fund road repairs and align marijuana taxation with other smoking products. The proposed hike would effectively double the total tax rate on cannabis in Michigan, drawing criticism from advocates who argue it would burden consumers and businesses. Other states have also contemplated or implemented similar tax hikes on marijuana as their markets mature. Michigan recently disbursed nearly $100 million in marijuana tax revenue to cities and tribes, a result of record sales in 2024.

The document is a newsletter from Marijuana Moment, dated September 16, 2025. Key topics include: a push from various groups for federal marijuana legalization, the expected availability of medical marijuana in Kentucky by next month, the Texas Supreme Court declining to hear an appeal on a local marijuana decriminalization law, a New York Assembly Health Committee hearing on psilocybin, and a new op-ed about pending congressional hemp legislation that could ban certain products. The newsletter also covers federal and state cannabis news, local and international updates, science and health studies related to cannabis and psychedelics, and business news in the cannabis industry.

The Appellate Court of Maryland ruled that delta-8 and delta-10 THC are illegal in the state, despite lax enforcement. While Maryland has a regulated adult-use industry for delta-9 THC, the court determined that synthesized hemp products containing delta-8 and delta-10 THC are not covered by the legalization program. This decision came after the Maryland Hemp Coalition argued that the state’s cannabis regulations created an unconstitutional monopoly. Separately, Maryland collected $18.4 million in cannabis industry tax revenue from April to June 2025.

A GOP-controlled congressional committee has approved a bill to repeal a Washington, D.C. law that expands expungements for marijuana possession offenses. The law, part of the Second Chance Amendment Act of 2022, automatically expunges marijuana possession records from before 2014. Critics like Rep. Eleanor Holmes Norton (D-DC) call the bill "paternalistic," while proponents argue it holds convicted criminals accountable. This action comes amidst ongoing congressional interference with D.C.'s cannabis laws, including an annual rider preventing D.C. from using its local tax dollars for regulated recreational marijuana sales, despite voter approval in 2014.

The House Appropriations Committee approved a bill to block the Trump
administration from rescheduling marijuana, while also continuing a
separate rider protecting state medical cannabis programs from federal
interference.

The court upheld Maryland’s cannabis licensing requirements for selling intoxicating products with hemp derivatives.

Standard Wellness Holdings LLC has appointed Rob McCourt as Vice President of Wholesale. He will be responsible for driving wholesale strategy, expanding market share, and building relationships with retail partners. McCourt was previously a co-founder and Executive Vice President of Revenue at Firelands Scientific, where he helped scale the company into a multi-state operator. He also held leadership roles at Cisco Systems and Verizon. Standard Wellness is a vertically integrated cannabis company operating in Ohio, Missouri, Utah, and Maryland.

Senator Rand Paul (R-KY) opposes a proposed blanket ban on hemp THC products, arguing that even a small amount of THC is crucial for the health effects of CBD products due to the "entourage effect." He believes such a ban would devastate the hemp industry and has introduced a bill, the Hemp Economic Mobilization Plan (HEMP) Act, to triple the legal THC concentration in hemp. While some colleagues, like Senator Mitch McConnell (R-KY), initially sought a complete ban, McConnell ultimately agreed to pull the language from an agriculture bill after Paul's procedural protest. The Congressional Research Service (CRS) also reported that such legislation would effectively prohibit hemp-derived cannabinoid products. Meanwhile, the alcohol industry is expressing concerns about unregulated hemp products, viewing cannabis as a threat to their market.

A GOP-controlled House committee has approved a spending bill that contains
provisions to block the Justice Department from rescheduling marijuana.

Dispensary growth in D.C. is causing oversaturation concerns, though tourism helps sales. Trulieve's acquisition of Harvest Health will strengthen its position in Maryland's medical cannabis market. Virginia's retail legalization debate shows a conflict between large operators and small businesses, while new products like THC seltzer indicate the state's move into cannabis beverages.

The provided text from "Marijuana Moment" summarizes recent news in cannabis policy, including criticism of the exclusion of marijuana banking provisions from a House spending bill, Pennsylvania Gov. Josh Shapiro's office urging lawmakers to focus on consensus-building for marijuana legalization, Texas Gov. Greg Abbott hinting at future action on intoxicating hemp products, and Massachusetts considering initiatives to recriminalize recreational marijuana sales. It also covers various state and federal developments, international news, scientific research, advocacy efforts, business updates, and cultural references related to cannabis.

A top aide to Pennsylvania's governor says lawmakers should stop introducing new marijuana legalization bills and instead focus on building consensus. The aide emphasized that any bill the governor signs into law must contain equity provisions, especially expungements for past cannabis convictions. The administration's other priorities include ending law enforcement's focus on marijuana criminalization, maintaining the medical cannabis program, and addressing the unregulated hemp market. The discussion also covered the ongoing legislative gridlock and the varying approaches to legalization, including debates over state-run vs. privately licensed sales models, and the differing revenue projections between the governor and a Republican gubernatorial candidate.

A Democratic congresswoman, Rep. Betty McCollum, is criticizing the exclusion of provisions to protect banks working with state-licensed marijuana and hemp businesses from a key spending bill. She expressed disappointment about the cannabis policy omissions, highlighting the need for all businesses to have access to financial services and emphasizing the growth of the hemp industry. While supporting cannabis banking access, McCollum also acknowledged Rep. Andy Harris's efforts to ban intoxicating hemp-derived cannabinoid products. Many hemp businesses operate in cash due to banks' fear of federal penalties. A bipartisan coalition of state attorneys general also called for a marijuana banking bill. Despite efforts, other legislative priorities have taken precedence, and the bill's introduction is not imminent. The spending bill does include a report directing federal agencies to assess state-level marijuana regulatory models and maintains provisions blocking Washington, D.C. from legalizing cannabis sales with its tax dollars.

Standard Wellness Holdings LLC acquired GreenBud LLC (Greenstock), a licensed dispensary in Seville, Ohio, for $1.35 million, increasing Standard Wellness's Ohio dispensaries to four. Standard Wellness, founded in 2017, is a cannabis company operating in Ohio, Missouri, Utah, and Maryland, with seven retail locations under The Forest brand.

A new federally funded study found that states where marijuana is criminalized have significantly more sales of lesser-regulated hemp cannabinoid products like delta-8 THC. Researchers at the University of California San Diego concluded that delta-8-THC use was highest among states that prohibit marijuana use. The study also found that delta-8 THC use was more common in states with no regulations on its sale. This suggests that people shift to alternatives that are easier to access, even if they are less well-studied or poorly regulated, when their state bans cannabis. Health experts are concerned about the public health risks of delta-8 THC due to the lack of research into its effects compared to delta-9 THC. There are ongoing discussions at federal and state levels to regulate or ban hemp-derived cannabinoids like delta-8 THC.

The provided text is a newsletter from "Marijuana Moment" dated September 3, 2025. Key topics include: RFK Jr.'s stance on psychedelics, a poll showing two-thirds of American voters support nationwide marijuana legalization, Nebraska activists filing a 2026 marijuana legalization initiative, and Delaware's strong first month of cannabis sales ($7.4 million). It also covers federal actions, state-level cannabis news (Maryland, Massachusetts, Michigan, Texas, Delaware, Oregon, Maine), international drug policy discussions, scientific studies on cannabis, and business and culture-related news in the cannabis industry. The newsletter encourages subscriptions and support via Patreon.

A new bill in Pennsylvania, SB 926, aims to protect parents who are medical marijuana patients from losing child custody or being subjected to drug tests solely based on their patient status. This legislation, introduced by Sen. John Kane, seeks to clarify existing state law and prevent lawful medical marijuana use from being used against parents in custody disputes. The push for this reform is happening alongside a broader effort to legalize adult-use marijuana in Pennsylvania, with several other bills and proposals currently under consideration, facing bipartisan support and opposition within the legislature.

Congressional Subcommittee Votes To Keep Blocking Marijuana Sales In D.C. As Trump Requested In Budget

Pennsylvania House Democrats are urging voters to pressure state senators to pass HB 1200, a bill to legalize marijuana and sell it through state-owned stores, citing health, safety, and revenue benefits. The bill narrowly passed the House but was rejected by a Senate committee. Despite bipartisan support among voters, the reform faces opposition from Senate Republicans. Other legalization proposals are in discussion, and supporters believe growing public sentiment will help overcome legislative hurdles. The governor also supports legalization, emphasizing competitiveness with surrounding states.

Senators Advance Bill Continuing Medical Marijuana Protections And Omitting House Proposal To Block Rescheduling

Ascend Wellness Holdings Inc. has launched a new e-commerce platform and "Ascenders Club" loyalty program. The loyalty program has four tiers (Blue, Gold, Platinum, and Legends Club) and offers personalized perks and benefits. The new platform includes an AI-powered recommendation engine, Ascend Pay for cashless transactions, and a new shopping app with integrated loyalty features. The "Ascenders Club" launched on July 15th, with existing customers automatically enrolled.

A Republican Pennsylvania senator, Dan Laughlin, believes that supporters of marijuana legalization are gaining votes to pass reform this session. He states that people prefer legalizing cannabis for revenue rather than increasing taxes to balance the budget. Laughlin, along with Sen. Sharif Street, introduced a bill to legalize adult-use cannabis. There are also other proposals, including a House companion version, under consideration. Despite previous setbacks, lawmakers are optimistic about passing a bill that would also include sealing and expunging cannabis-related convictions. However, there are conflicting views on the model of cannabis sales (state-run vs. private businesses) and the political dynamic with a GOP-controlled Senate. Despite these challenges, polls show strong public support for legalization. The governor also supports legalization, emphasizing economic benefits and public safety.

A Democratic Pennsylvania House lawmaker, Rep. Amen Brown, has filed a new marijuana legalization bill, mirroring a bipartisan Senate proposal. He argues that legalization would expand patient access, strengthen the state's cannabis infrastructure, ensure product safety, combat the black market, and address disproportionate arrests in communities of color. Brown emphasizes the economic benefits, citing other states, and warns against high tax rates that could drive consumers to illicit markets. Other lawmakers have also introduced similar bills, highlighting the bipartisan support and economic opportunities for Pennsylvania. Despite broad public support, legislative efforts have faced hurdles, particularly regarding state-run stores and the need for Republican support in the Senate.

A congressional committee approved a spending bill that includes provisions to block the Justice Department from rescheduling marijuana and maintains protections for state medical cannabis programs, with new language for enhanced penalties for sales near schools. The bill would specifically prevent the Justice Department from using funds to reschedule or deschedule marijuana. The Drug Enforcement Administration's marijuana rescheduling process remains stalled. Separately, discussions around marijuana policy reform and rescheduling efforts continue among politicians and advocates.

The text is a newsletter from Marijuana Moment, dated July 15, 2025. Key topics include: a House committee blocking marijuana rescheduling while protecting medical cannabis laws; a Senate committee report on cannabis marketing and hemp rules, and support for psychedelic research; the National Institute on Drug Abuse ending its marijuana cultivation contract with the University of Mississippi; Delaware's governor weighing local control against the slow start of the legal cannabis market; and new marijuana legalization bills in the Pennsylvania House and Senate. Other sections cover federal and state news, local incidents, international developments, science and health updates, advocacy, business news, and culture.

Bipartisan lawmakers in Pennsylvania have filed new bills to legalize marijuana. The House has filed legislation establishing the Keystone Cannabis Authority and the Community Opportunity Fund, aiming to close a budget gap and create jobs. Meanwhile, a companion bill to a Senate legalization proposal is also expected to be filed in the House. Lawmakers supporting legalization emphasize economic opportunity, justice, equity, and responsible regulation, including expungement of low-level offenses. The governor has called for adult-use marijuana legalization, stressing competitiveness and the need to address the illicit market. Despite bipartisan support among voters, legislative efforts have stalled due to conflicting views, particularly on state-run stores versus private sales, and the need for Republican support in the Senate.

A new report from the Senate Appropriations Committee expresses concerns about misleading marketing of cannabis products and the need for revised hemp rules, while also supporting research into psychedelic medicines. The report is attached to a spending bill that initially proposed a federal ban on hemp products with any quantifiable THC, but senators agreed to delay implementation for a year. The committee is concerned about non-FFDCA compliant cannabis products making unsubstantiated health claims. They also encourage the FDA to collaborate with the VA, DoD, and NIH on psychedelic research. On hemp, the committee recognizes consumer demand and the need for clear, science-based guidance, directing the FDA to engage with industry stakeholders and seek information from states on cannabinoid limits and age restrictions. Other provisions include improving data sharing between state and federal authorities, supporting hemp cultivar development, and establishing a hemp germplasm repository. Senator Mitch McConnell is reportedly behind the restrictive cannabis language in the bill. Senator Rand Paul has filed a bill to triple the legal THC concentration in hemp. The proposed legislation would effectively ban most commonly marketed hemp products. The Wine & Spirits Wholesalers of America (WSWA) has called on Congress to dial back the ban, advocating for the legalization of naturally derived cannabinoids and prohibiting synthetic items.

Ceres Naturals, a Maryland-licensed cannabis processor, entered a Consent Order with the Maryland Cannabis Administration following an inspection that revealed several regulatory violations. These violations included issues with visitor logs, cannabis storage and disposal, unregistered and untrained staff, and equipment sanitation. The company agreed to corrective actions to avoid a formal hearing, underscoring the state's strict regulation of cannabis businesses.

The author, Ryan Basore, a former federal prisoner for medical cannabis cultivation, launched Redemption Cannabis and the Redemption Foundation. His cannabis brand is now available in West Virginia, where he was incarcerated. The Redemption Foundation provides expungements and financial support to non-violent cannabis offenders still in prison, partnering with organizations like Mission Green and the Last Prisoner Project. Basore emphasizes that despite widespread legalization, many people remain incarcerated for cannabis offenses, and federal law, which classifies cannabis as a Schedule I drug, needs to change for true justice. He states that 10% of Redemption Cannabis licensing revenue supports incarcerated individuals and their release, highlighting that buying their products contributes to the pursuit of justice.

A new study found that psychedelic retreats using psilocybin and ayahuasca significantly improved mental health in military veterans, including reductions in PTSD, depression, and anxiety symptoms, improved sleep, quality of life, and post-deployment reintegration. Psilocybin showed greater overall improvements, while ayahuasca was slightly more effective for PTSD. The study emphasizes the positive impact of psychedelic retreats on veterans' mental health and general well-being, highlighting the potential benefits of the communal experience. The study comes as pressure builds at state and federal levels to ease access to psychedelics, especially for veterans with PTSD, with government officials expressing interest in expanding research and access.

Bipartisan Pennsylvania Senators Dan Laughlin (R) and Sharif Street (D) have filed a bill to legalize adult-use marijuana in the state. The legislation aims to create a Cannabis Control Board, protect consumers, expunge past offenses, and reinvest in communities impacted by prohibition. Supporters highlight the economic benefits and the need for Pennsylvania to catch up with neighboring states that have already legalized cannabis. While there is bipartisan support among voters, the reform has faced legislative hurdles, particularly in the GOP-controlled Senate. Governor Josh Shapiro (D) has also called for legalization, emphasizing the economic advantages and the need to regulate the illicit market.

A Senate committee approved a bill to ban consumable hemp products with any quantifiable amount of THC, but delayed implementation for one year. Sen. Mitch McConnell (R-KY) supported the ban to close a "loophole" from the 2018 Farm Bill that led to intoxicating cannabinoid products. Sen. Jeff Merkley (D-OR) expressed concern that the ban would be overbroad, affecting non-intoxicating products like CBD. Industry experts fear it would effectively ban most CBD products due to trace THC. The new bill text has not been released, but sources say it's similar to a House bill. There are some differences in the definition of "quantifiable" THC and an exception for FDA-approved drugs. The alcohol industry also advocates for maintaining the legality of naturally derived cannabinoids while banning synthetic items.

A new federally funded study published in the Journal of Affective Disorders found that medical marijuana significantly decreased self-reported anxiety and depression in patients within three months of initiation, with sustained reductions over six months. The study, conducted by Johns Hopkins University and funded in part by NIDA, observed 33 adults in Maryland who used medical cannabis. Most participants chose THC-dominant products, and while reporting mental health benefits, also noted a decline in perceived driving ability and an increase in feeling high. Authors recommend further controlled clinical trials to investigate efficacy and safety. Other recent research also supports cannabis, particularly CBD, for its potential antidepressant and anti-anxiety properties.

Maryland is implementing new cannabis restrictions on July 1, capping THC content in unlicensed products and increasing regulatory oversight. Unlicensed products are prohibited from containing more than 0.5 mg THC per serving or 2.5 mg per package, with violators facing misdemeanor charges and fines. Licensed dispensaries are unaffected, but unlicensed retailers must comply. These changes aim to protect consumers from untested or potent illicit goods.

The cannabis brand Cookies, founded by rapper Berner, is opening its East Coast flagship in Washington, D.C. Maryland is also improving cannabis equity with a new CEO Accelerator Program launched on June 24.

Senator Mitch McConnell is reportedly pushing legislation to ban consumable hemp products with quantifiable amounts of THC, which stakeholders say would effectively eliminate much of the consumable hemp market, including most CBD products due to trace THC. This move is seen as an attempt to close a "loophole" in the 2018 Farm Bill that led to the proliferation of unregulated intoxicating cannabinoid products. The proposed language, similar to what passed the House Appropriations Committee, is facing opposition from some senators and industry groups who argue it would devastate the American hemp industry, though others are unconcerned about potential Senate opposition.

This newsletter from Marijuana Moment covers various cannabis and psychedelics-related news. Key topics include a federal judge upholding a gun ban for marijuana users, a former Navy SEAL discussing psychedelic therapy for PTSD, and a scientific review on what gives cannabis strains their aroma and flavor. It also highlights a study on cannabis consumption in California, Maryland's plan for a state-owned cannabis incubator, and updates on cannabis legislation and regulation in several states. Other sections touch on international drug policy, science and health studies related to cannabis and psychedelics, and business news in the cannabis industry.

Maryland Governor Wes Moore announced that the state will find a new location for its planned $7 million cannabis incubator project due to local opposition to the original site in Catonsville. The new site will not be near residential communities or schools. The project aims to be the country's first state-owned cannabis incubator, allowing up to 110 microbusinesses to store and process cannabis products.

The July 7, 2025 edition of Marijuana Moment’s newsletter covers several key developments in cannabis and psychedelics policy. The Czech Republic Senate passed a bill legalizing marijuana possession and home cultivation, and allowing medical psilocybin. VA Secretary Doug Collins praised psychedelics' effectiveness in treating veterans. Sen. Jeff Merkley (D-OR) indicated that a cannabis banking bill is pending, delayed by other legislative priorities. A new study links frequent cannabis use with increased daily sexual desire. Other stories include California and Texas lawmakers' debates on marijuana taxes and hemp product regulations, updates on medical cannabis operations in Rhode Island and Delaware, and a survey challenging "lazy stoner" stereotypes in Des Moines, Iowa. Federal news includes the Bureau of Land Management’s contract for cannabis cultivation reclamation, a warning about synthetic kratom, and a proposed amendment on minors' access to sensitive content online. State-level updates cover expungement laws in Maryland, Georgia's medical marijuana study committee, crackdowns on intoxicating hemp in Arizona, product recalls in California and Minnesota, license payment reminders in Colorado, free marijuana locking bags in Michigan, and a cannabis regulation collaborative in Missouri. Local news includes Dallas, Texas officials seeking an injunction against voter-approved marijuana decriminalization. Internationally, an Israeli official upheld the rejection of tariffs on Canadian medical cannabis imports. Science and health news highlights phytocannabinoids' potential as antifungal treatments and psychedelics' potential to alleviate pain. Business news includes Blum Holdings, Inc. acquiring a Northern California dispensary.

Maryland launched a cannabis equity ecosystem, including a CEO Accelerator Program, on June 24, 2025. This program, led by the Office of Social Equity, supports 191 social equity licensees with business development, financial training, and mentorship, in partnership with NuProject and Coppin State University.

This article from Marijuana Moment summarizes cannabis-related news. Key topics include Wisconsin's rejection of marijuana amendments, California ending cannabis testing for prison guards, a lawsuit against the federal government regarding marijuana use and security clearances, and researchers arguing that marijuana's Schedule I status hinders research. It also covers federal and state-level developments, international updates on CBD products, scientific reviews on cannabinoids and psychedelics, business news from AYR Wellness Inc. and Washington D.C. dispensaries, and a cultural mention of Mike Tyson.

California senators have passed a bill to ratify a labor agreement that will end random marijuana drug tests for most correctional officers, acknowledging a state law protecting employees from discrimination based on off-duty cannabis use. However, officers with commercial driver's licenses will still be tested. This is part of an ongoing evolution of California employment policies since cannabis legalization, which has included removing past marijuana use questions for police applicants and prohibiting employers from penalizing employees for lawful off-duty use. The article also mentions related developments in Oregon, Maryland, and Delaware.

Researchers involved in a federally funded clinical trial on marijuana highlight the critical importance of further study into the substance, given its widespread use. They argue that classifying cannabis as a Schedule I substance creates a paradox, as it heavily restricts the very studies needed to prove its medical value. The researchers advocate for moving marijuana to Schedule III to ease restrictions, increase NIH funding, and improve access to government-approved cannabis supplies. They also point out obstacles such as systemic underfunding, institutional hesitancy due to stigma, navigating multiple federal agencies, and limited supply of NIDA-approved marijuana. The article emphasizes that reform is crucial to close the evidence gap and address public health concerns.

The July 3, 2025 edition of the Marijuana Moment newsletter highlights several key developments in cannabis policy, including Hawaii's expansion of medical cannabis access, Florida's progress toward a 2026 legalization initiative, New Jersey's acceptance of marijuana consumption lounge applications, and a poll indicating most cannabis consumers use it as a prescription medication substitute. It also covers federal discussions on marijuana rescheduling, state-level legislative changes and regulatory actions, and international developments in Georgia. The newsletter also touches on scientific research into cannabis and psychedelics, and business news within the cannabis industry.

TerrAscend Corp. is exiting the Michigan cannabis market by selling its assets, including cultivation and processing facilities, 20 retail dispensaries, and real estate, to pay down debt. This "strategic" decision, according to Executive Chairman Jason Wild, is due to the difficulty of the Michigan market and will allow the company to focus on its core markets in the northeastern U.S. (New Jersey, Maryland, Pennsylvania, and Ohio). The exit will result in a 21% workforce reduction (approximately 1,200 employees) by the end of Q3 2025. Following the plan's completion, TerrAscend will operate 19 dispensaries and four cultivation/processing facilities across five U.S. states and Toronto. The Michigan exit is expected to be mostly completed in the second half of 2025 and will be reported as discontinued operations starting in Q2 financial results.

New York-based Cannabis Public Policy Consulting LLC was awarded a $238,700 contract to study Missouri's marijuana market for the next year. The study aims to determine if and when the state needs to issue additional cannabis facility licenses, and to provide information on the economic stability of the regulated market, including its impact on economically distressed areas. Missouri's cannabis market has been successful, with $1.46 billion in sales in 2024, partly due to limiting the number of licenses. The study will also help create a plan to promote ownership and employment in the marijuana industry for people from economically distressed areas.

Summary: D.C., Virginia and Maryland cannabis news from June 25 to July 1, 2025.